BioNTech SE (BNTX) Prepaid Assets (2018 - 2022)

BioNTech SE (BNTX) posted Prepaid Assets of $164.0 million for Q3 2022, up 229.91% sequentially from $49.7 million in Q2 2022.

BioNTech SE (BNTX) Prepaid Assets (2018 - 2022) Analysis & Trends

BioNTech SE has reported Prepaid Assets for 5 years, with the latest figure at $164.0 million in Q3 2022.

Quarterly Prepaid Assets changed N/A year-over-year to $164.0 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $164.0 million (changed N/A YoY) and the FY2021 annual result came in at $76.8 million, up 10.27% from the prior year.
Prepaid Assets improved to $164.0 million in Q3 2022 per BNTX's latest filing, from $49.7 million in the prior quarter.
Over five years, Prepaid Assets peaked at $164.0 million in Q3 2022 and troughed at $10.0 million in Q4 2019.
A 5-year average of $60.9 million and a median of $72.7 million in 2020 frame the typical range for Prepaid Assets.
The sharpest annual moves came in 2020 and 2022: Prepaid Assets surged 624.52% in 2020, then declined 13.24% in 2022.
Over 5 years, Prepaid Assets stood at $10.5 million in 2018, then decreased by 4.03% to $10.0 million in 2019, then soared by 624.52% to $72.7 million in 2020, then advanced by 2.08% to $74.2 million in 2021, then surged by 120.96% to $164.0 million in 2022.
According to Business Quant data, Prepaid Assets over the past three periods registered $164.0 million, $49.7 million, and $72.8 million for Q3 2022, Q2 2022, and Q1 2022 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	BioNTech SE	23.54 Bn	5.15 Bn	668.28 Mn

Download Data